CareDx to Participate in Upcoming Investor Conference
August 15 2018 - 09:00AM
CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company
focused on the discovery, development and commercialization of
clinically differentiated, high-value diagnostic solutions for
transplant patients, today announced that Peter Maag, Chief
Executive Officer, and Michael Bell, Chief Financial Officer, will
be participating in the H. C. Wainwright 20th Annual Global
Investment Conference, to be held on September 4-6, 2018 at the St.
Regis New York, in NYC. The company is scheduled to present
on Thursday, September 6, 2018 at 10:25 AM ET.
A live audio webcast of the H. C. Wainwright 20th Annual Global
Investment Conference presentation will be available online from
the investor relations section of the CareDx website at
https://investors.caredxinc.com/. The webcast replay of the
presentation will be available approximately one hour following the
conclusion of the live presentation and will be available on the
Company’s website for 90 days.
About CareDx CareDx,
Inc., headquartered in Brisbane, California, is a molecular
diagnostics company focused on the discovery, development and
commercialization of clinically differentiated, high-value
diagnostic solutions for transplant recipients. CareDx offers
products along the pre- and post-transplant testing continuum.
For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.Sasha KingChief Commercial
Officer415-287-2393sking@caredx.com
Investor RelationsDavid ClairIntegrated Corporate Relations,
Inc.646-277-1266david.clair@icrinc.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Feb 2024 to Mar 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Mar 2023 to Mar 2024